CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells. - Hayden-Ledbetter MS; Cerveny CG; Espling E; Brady WA; Grosmaire LS; Tan P; Bader R; Slater S; Nilsson CA; Barone DS; Simon A; Bradley C; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2009)